| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $5.11M | - | |
| Other | 21.6K | $1.45M | - | |
| Other | 15.4K | $1.04M | -5,538 | |
| Dir | 8.0K | $538.4K | - | |
| Dir | 8.0K | $538.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2019 | Labrucherie Gil M84 | SVP, COO &CFO | Sale+OE | 25,000 | $15.83 | $395,750.00 | -9.9% | |
| Sep 30, 2019 | Ajer Jeffrey Robert58 | Director | Sell | 2,375 | $18.06 | $42,892.50 | -9.6% | |
| Sep 27, 2019 | Lingnau Lutz | Director | Sell | 3,000 | $17.84 | $53,520.00 | -10.1% | |
| Sep 27, 2019 | Chess Robert84 | Director | Sell | 4,000 | $17.99 | $71,960.00 | -1.4% | |
| Sep 20, 2019 | Ajer Jeffrey Robert58 | Director | Sell | 2,250 | $20.24 | $45,540.00 | -11.0% | |
| Sep 16, 2019 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sale+OE | 25,000 | $20.52 | $513,000.00 | -14.1% | |
| Sep 5, 2019 | Doberstein Stephen K | SVP &Chief Scientific Officer | Buy | 15,000 | $17.28 | $259,200.00 | +16.2% | |
| Aug 16, 2019 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 1,809 | $18.15 | $32,833.35 | -1.1% | |
| Aug 16, 2019 | Robin Howard W58 | President &CEO | Sell | 12,551 | $18.15 | $227,800.65 | -4.2% | |
| Aug 16, 2019 | Nicholson John | SVP &Chief Operating Officer | Sell | 3,819 | $18.15 | $69,314.85 | -2.3% |